A PROSPECTIVE OPEN-LABEL TRIAL OF EXTENDED-RELEASE LIQUID METHYLPHENIDATE FOR THE TREATMENT OF ATTENTION DEFICIT/HYPERACTIVITY DISORDER (ADHD) IN ADULTS WITH HIGH-FUNCTIONING AUTISM SPECTRUM DISORDER: AN INTERIM ANALYSIS

被引：0
|
作者：
Joshi, Gagan [1 ]
Hoskova, Barbora [1 ]
Fitzgerald, Maura [1 ]
Ceranoglu, Tolga Atilla [1 ]
Yule, Amy [1 ]
Fried, Ronna S. [1 ]
Galdo, Maribel [1 ]
Belser, Abigail H. [1 ]
Tornberg, Haley [1 ]
Biederman, Joseph [1 ]
机构：
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY | 2017年 / 56卷 / 10期
关键词：
D O I：
10.1016/j.jaac.2017.09.301
中图分类号：
B844 [发展心理学（人类心理学）];
学科分类号：
040202 ;
摘要：
5.18
引用
收藏
页码：S259 / S259
页数：1
相关论文
共 50 条
  • [41] Population pharmacodynamic modeling of various extended-release formulations of methylphenidate in children with attention deficit hyperactivity disorder via meta-analysis
    Kimko, Holly
    Gibiansky, Ekaterina
    Gibiansky, Leonid
    Starr, H. Lynn
    Berwaerts, Joris
    Massarella, Joseph
    Wiegand, Frank
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2012, 39 (02) : 161 - 176
  • [42] Prospective, Naturalistic, Pilot Study of Open-Label Atomoxetine Treatment in Preschool Children with Attention-Deficit/Hyperactivity Disorder
    Ghuman, Jaswinder K.
    Aman, Michael G.
    Ghuman, Harinder S.
    Reichenbacher, Thomas
    Gelenberg, Alan
    Wright, Ron
    Rice, Sydney
    Fort, Carolyn
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2009, 19 (02) : 155 - 166
  • [43] Population pharmacodynamic modeling of various extended-release formulations of methylphenidate in children with attention deficit hyperactivity disorder via meta-analysis
    Holly Kimko
    Ekaterina Gibiansky
    Leonid Gibiansky
    H. Lynn Starr
    Joris Berwaerts
    Joseph Massarella
    Frank Wiegand
    Journal of Pharmacokinetics and Pharmacodynamics, 2012, 39 : 161 - 176
  • [44] A PROSPECTIVE OPEN-LABEL TRIAL OF LONG-ACTING LIQUID METHYLPHENIDATE FOR THE TREATMENT OF ADHD IN INTELLECTUALLY CAPABLE ADULTS WITH ASD
    Joshi, Gagan
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2019, 58 (10): : S331 - S331
  • [45] Whey Protein (Ma'aljohon) as a Complementary Therapy for Treatment of Attention-deficit/Hyperactivity Disorder (ADHD): A Randomized Open-label Controlled Clinical Trial
    Mostajeran, Zeinab
    Mosavat, Seyed Hamdollah
    Najafi, Mostafa
    Emtiazy, Majid
    Hashempur, Mohammad Hashem
    GALEN MEDICAL JOURNAL, 2020, 9 : 1 - 9
  • [46] The Open-Label Treatment of Attention-Deficit/Hyperactivity Disorder in 4-and 5-Year-Old Children with Beaded Methylphenidate
    Maayan, Lawrence
    Paykina, Natalya
    Fried, Jane
    Strauss, Tara
    Gugga, S. Sonia
    Greenhill, Laurence
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2009, 19 (02) : 147 - 153
  • [47] Quetiapine addition in methylphenidate treatment-resistant adolescents with comorbid attention-deficit/hyperactivity disorder, conduct/oppositional-defiant disorder, and aggression: A prospective, open-label study
    Kronenberger, William G.
    Giauque, Ann L.
    Lafata, Deborah E.
    Bohnstedt, Bradley N.
    Maxey, Laura E.
    Dunn, David W.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2007, 17 (03) : 334 - 347
  • [48] Effect of osmotic-release oral system methylphenidate on learning skills in adolescents with attention-deficit/hyperactivity disorder: an open-label study
    Na, Kyoung-Sae
    Lee, Soyoung Irene
    Hong, Sungdo David
    Kim, Ji-Hoon
    Shim, Se-Hoon
    Choi, Jeewook
    Yang, Jaewon
    Lee, Moon-Soo
    Joung, Yoo-Sook
    Kim, Eui-Jung
    Park, Joon-Ho
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2013, 28 (04) : 184 - 192
  • [49] The clinical characteristics of the adolescent attention deficit/hyperactivity disorder (ADHD) patients and treatment effects of an extended-release preparation of methylphenidate (more large sample size than previous study)
    Oh, E. Y.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S530 - S531
  • [50] PHARMACOKINETICS OF A NOVEL, EXTENDED-RELEASE FORMULATION OF METHYLPHENIDATE (PRC-063) IN ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER AND IN HEALTHY ADULTS AT STEADY STATE
    Quinn, Declan Martin
    Bode, Twyla D.
    Donnelly, Graeme
    Reiz, Joseph L.
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2016, 55 (10): : S219 - S220
12345